Phoslax

Phoslax is a grape-flavored laxative medication manufactured by Odan Laboratories Ltd. It contains a combination of monobasic sodium phosphate (2.4 g per teaspoon) and dibasic sodium phosphate (0.9 g per teaspoon). This medication belongs to the class of saline laxatives, which work by increasing fluid in the small intestine to stimulate bowel movements. ## Mechanism of Action Phoslax works as a saline laxative by drawing water into the intestines, which increases fluid in the small intestine. This action typically results in a bowel movement within 30 minutes to 6 hours after administration. The increased fluid softens the stool and stimulates intestinal contractions, facilitating evacuation of the bowel. ## Uses Phoslax is primarily used to: - Relieve occasional constipation - Clean or empty the bowels before certain medical procedures (such as colonoscopy) ## Administration The medication comes in a grape-flavored liquid form and should be taken exactly as directed by a healthcare provider. It's important to drink plenty of clear liquids during and after treatment to prevent dehydration. ## Important Safety Information Patients should be aware of potential risks associated with sodium phosphate products: - Can cause serious kidney damage in some cases - Should not be used more often than once in 24 hours or for more than 3 days unless directed by a doctor - Should not be combined with other laxative products - May cause dehydration if adequate fluid intake is not maintained Common side effects may include bloating, nausea, vomiting, and stomach pain. ## Precautions Particular caution should be exercised in patients with: - Kidney problems - Heart conditions - Electrolyte imbalances - Dehydration - Certain medications that may interact with sodium phosphate products Patients should consult their healthcare provider before using this medication, especially if they have any underlying medical conditions or are taking other medications.

Brand names

Phoslax

Other names

sodium phosphate/potassium phosphateoral phosphate challenge